Molina Healthcare (MOH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
The annual meeting will be held virtually on May 6, 2026, with voting open to shareholders of record as of March 9, 2026.
Key proposals include director elections, executive compensation advisory vote, auditor ratification, equity plan amendment, and a charter amendment for special meetings.
The company continues to focus on government-sponsored healthcare, serving 5.5 million members in 21 states, and has executed several new contracts and acquisitions in 2025-2026.
Voting matters and shareholder proposals
Shareholders will vote on electing ten directors, approving executive compensation (say-on-pay), ratifying Ernst & Young LLP as auditor, amending the 2025 Equity Incentive Plan to add 1.5 million shares, and amending the Certificate of Incorporation to allow holders of 20% of shares to call special meetings.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
Ten director nominees, including one new nominee, are up for election for one-year terms.
The board emphasizes diversity, independence (all but the CEO are independent), and a mix of tenures, with 12-year term limits for new independent directors.
Board committees include audit, compensation, governance and nominating, compliance and quality, and finance, all composed of independent directors.
The chairman and CEO roles are separated, with an independent chairman.
Annual board and committee self-evaluations and director education are conducted.
Latest events from Molina Healthcare
- Key votes include director elections, executive pay, auditor ratification, and expanded shareholder rights.MOH
Proxy filing23 Mar 2026 - Key votes include director elections, pay, auditor, equity plan, and special meeting rights.MOH
Proxy Filing13 Mar 2026 - 2025 earnings fell short on cost pressures; 2026 outlook cautious with Medicare Part D exit ahead.MOH
Q4 20256 Feb 2026 - Premium revenue up 17%, adjusted EPS $5.86, and guidance reaffirmed for 2024.MOH
Q2 20243 Feb 2026 - Q3 premium revenue up 18% and GAAP EPS up 34%; guidance reaffirmed.MOH
Q3 202418 Jan 2026 - Targeting $52–$55B revenue and 13%–15% EPS growth by 2027 with strong margin discipline.MOH
Investor Day 202415 Jan 2026 - Premium revenue up 19% in 2024; 2025 outlook targets $42B and strong EPS growth.MOH
Q4 202429 Dec 2025 - Premium revenue up 12% and adjusted EPS up 6% in Q1 2025; 2025 guidance reaffirmed.MOH
Q1 202524 Dec 2025 - Board recommends all management proposals, highlights strong performance and governance.MOH
Proxy Filing1 Dec 2025